About the organisation
The Asian Fund for Cancer Research Limited (AFCR) is committed to fund cancer research, especially those cancers prevalent in Asian populations, and promote global collaborations for high impact to save the lives of cancer patients. We believe that research holds the key that may end cancer. That’s why at AFCR, we place the highest priority in advancing cutting-edge cancer research in all important fields that will lead to better preventative methods, advanced diagnostic tools, more effective treatment approaches. We fund projects in a variety of important research fields, such as overcoming cancer’s resistance to chemotherapy, developing new screening tests for early detection, optimizing approaches of personalized medicine, and stopping cancer metastasis, etc. AFCR provides the public with a wide variety of in-depth, user-friendly cancer prevention information and healthy lifestyle suggestions. We help the community understand the latest scientific achievements and their potential significance to improve the prevention, diagnosis and treatment of cancer. Armed with this knowledge, people can better protect themselves against cancer.
Contact
- Room 2914, Hong Kong Plaza 188 Connaught Road West, Hong Kong, Hong Kong
Focus Areas
Governance & transparency
- No
- No
- No
Annual / Impact Reports
Charity Finder does not have any annual/impact reports for this charity yet. Submit documents.
News feed
Recent items from a feed this charity publishes. Email, social media, and the rest of their website may be more current.
- Breast Cancer Risk: Separating Myths from Facts
Breast cancer is one of the most commonly diagnosed cancers worldwide, yet misconceptions about what increases or reduces breast cancer risk remain common. According to the World Health Organization (WHO), breast cancer caused an estimated 694,000 deaths globally in 2024 and was… The post Breast Cancer Risk: Separating Myths from Facts appeared first on Asian Fund for Cancer Research Limited.
- World Cancer Congress 2026: Turning Cancer Innovation into Patient Impact
Cancer science is creating new possibilities at an extraordinary pace, but the need for progress continues to grow. In Hong Kong, about 40 people die from cancer every day. Worldwide, approximately one in five people will develop cancer during their lifetime, with… The post World Cancer Congress 2026: Turning Cancer Innovation into Patient Impact appeared first on Asian Fund for Cancer Research Limited.
- From Early Vision to Emerging Opportunity
AFCR’s Continuing Commitment to Hong Kong’s Biomedical Innovation Ecosystem A Look Back from 2022 to 2026 2022: Asking an Important Question In 2022, the Asian Fund for Cancer Research Limited (AFCR) convened a multidisciplinary Think-Tank Forum at BIOHK around a forward-looking question:… The post From Early Vision to Emerging Opportunity appeared first on Asian Fund for Cancer Research Limited.
Other
Does not receive recurrent funding from the Social Welfare Department
- 91/7750
- C0994957
- 09/09/2005
Disclaimer
If you represent this organisation, you can claim the listing and update the public profile yourself. Anyone can suggest a correction; we review those before they are applied. Details may still be incomplete or out of date and should be independently verified. We update listings from the IRD's monthly Section 88 list. You should still confirm current tax-exempt status yourself on the IRD search before you rely on it. Read full disclaimer.
Share
Reviews
No written reviews yet.
